{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:11:49Z","timestamp":1792782709247,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"A.C.Camargo Cancer Center","id":[{"id":"https:\/\/ror.org\/03025ga79","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Patients with cancer represent a substantial and growing proportion of the ICU population. Although short-term survival has improved, it remains unclear how often anticancer treatment is resumed after critical illness. We aimed to synthesize the available evidence on treatment resumption following ICU discharge in adult patients with cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched PubMed, Embase, Scopus, and Web of Science from inception to February 24, 2025 (PROSPERO CRD420251080476). We included studies reporting resumption of systemic anticancer treatment after unplanned ICU admission in adults with solid or hematological malignancies. The primary outcome was the proportion of patients resuming any anticancer treatment after discharge. The secondary outcome was resumption of the originally planned treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty studies encompassing 3,551 patients were included. Fifteen studies encompassed patients with solid cancer (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u20091800), three patients with hematological cancer (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009261), and two included both solid and hematological malignancies (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u20091490). Two studies were multicenter. The pooled rate of resuming any anticancer treatment after discharge was 61% (95% CI, 51\u201370%), with substantial heterogeneity (I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200995.6%). Resumption rates were 60% (95% CI, 48\u201371%) in patients with solid tumors and 77% (95% CI, 56\u201389%) in patients with hematological malignancies. Eight studies (1,736 patients) assessed resumption of the original planned regimen, with a pooled rate of 48% (95% CI, 36\u201360%) at 6 months post-discharge.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Most patients surviving ICU admission resume anticancer therapy, but fewer than half continue their originally planned treatment. ICU admission may represent a turning point in the oncologic trajectory, highlighting the need for early post-ICU reassessment of disease status, functional capacity, and patient preferences. However, there is a lack of prospective multicenter studies with standardized definitions of treatment resumption and predefined assessment time points.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-11135-6","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:10:16Z","timestamp":1788192616000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of intensive care unit admission on the resumption of treatment in patients with cancer: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0045-0794","authenticated-orcid":false,"given":"Raisa","family":"do Val Roso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8940-9130","authenticated-orcid":false,"given":"Renato","family":"Daltro-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0551-9533","authenticated-orcid":false,"given":"Laveena","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0522-7445","authenticated-orcid":false,"given":"Antonio Paulo","family":"Nassar Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"11135_CR1","volume":"36","author":"AP Nassar Junior","year":"2024","unstructured":"Nassar Junior AP, Santos LIO (2024) Demystifying the oncologic patient in the intensive care unit. Crit Care Sci 36:e20240054en","journal-title":"Crit Care Sci"},{"issue":"3","key":"11135_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00134-023-06988-y","volume":"49","author":"G Dumas","year":"2023","unstructured":"Dumas G, Pastores SM, Munshi L (2023) Five new realities in critical care for patients with cancer Intensive Care Med;49(3):345-348","journal-title":"Intensive Care Med"},{"issue":"8","key":"11135_CR3","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1001\/jamaoncol.2015.2855","volume":"1","author":"K Puxty","year":"2015","unstructured":"Puxty K, McLoone P, Quasim T, Sloan B, Kinsella J, Morrison DS (2015) Risk of Critical Illness Among Patients With Solid Cancers: A Population-Based Observational Study JAMA Oncol;1(8):1078-1085","journal-title":"JAMA Oncol"},{"issue":"4","key":"11135_CR4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00134-024-07349-z","volume":"50","author":"L Munshi","year":"2024","unstructured":"Munshi L, Dumas G, Rochwerg B, Shoukat F, Detsky M, Fergusson DA (2024) Long-term survival and functional outcomes of critically ill patients with hematologic malignancies: a Canadian multicenter prospective study Intensive Care Med;50(4):561-572","journal-title":"Intensive Care Med"},{"issue":"8","key":"11135_CR5","volume":"6","author":"APA Pra\u00e7a","year":"2024","unstructured":"Pra\u00e7a APA, Nassar Junior AP, Ferreira AM, Caruso P (2024) Decreased long-term survival of patients with newly diagnosed cancer discharged home after unplanned ICU admission: a prospective observational study. Crit Care Explor 6(8):e1136","journal-title":"Crit Care Explor"},{"issue":"2","key":"11135_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00134-020-06184-2","volume":"47","author":"FG Zampieri","year":"2021","unstructured":"Zampieri FG, Romano TG, Salluh JIF, Taniguchi LU, Mendes Jr. PV, Nassar AP (2021) Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study Intensive Care Med;47(2):170-179","journal-title":"Intensive Care Med"},{"issue":"7","key":"11135_CR7","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00134-019-05653-7","volume":"45","author":"M Darmon","year":"2019","unstructured":"Darmon M, Bourmaud A, Georges Q, Soares M, Jeon K, Oeyen S (2019) Changes in critically ill cancer patients\u2019 short-term outcome over the last decades: results of systematic review with meta-analysis on individual data. Intensive Care Med 45(7):977\u2013987","journal-title":"Intensive Care Med"},{"issue":"1","key":"11135_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13054-023-04415-8","volume":"27","author":"BW Tillmann","year":"2023","unstructured":"Tillmann BW, Hallet J, Sutradhar R, Guttman MP, Coburn N, Chesney TR (2023) The impact of unexpected intensive care unit admission after cancer surgery on long-term symptom burden among older adults: a population-based longitudinal analysis Crit Care;27(1):162","journal-title":"Crit Care"},{"issue":"1","key":"11135_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.chest.2021.02.034","volume":"160","author":"C Teixeira","year":"2021","unstructured":"Teixeira C, Rosa RG, Sganzerla D, Sanchez EC, Robinson CC, Dietrich C (2021) The burden of mental illness among survivors of critical care-risk factors and impact on quality of life: a multicenter prospective cohort study. Chest 160(1):157\u2013164","journal-title":"Chest"},{"key":"11135_CR10","doi-asserted-by":"crossref","unstructured":"Vizzacchi BA, Dettino ALA, Besen B, Caruso P Jr, Nassar AP (2024) Delirium during critical illness and subsequent change of treatment in patients with cancer: a mediation analysis. Crit Care Med 52(1):102\u2013111","DOI":"10.1097\/CCM.0000000000006070"},{"issue":"1","key":"11135_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13613-024-01366-3","volume":"14","author":"S Benguerfi","year":"2024","unstructured":"Benguerfi S, Mess\u00e9ant O, Painvin B, Camus C, Maamar A, Gacouin A (2024) Factors associated with cancer treatment resumption after ICU stay in patients with solid tumors. Ann Intensive Care 14(1):135 https:\/\/doi.org\/10.1186\/s13613-024-01366-3","journal-title":"Ann Intensive Care"},{"key":"11135_CR12","doi-asserted-by":"crossref","unstructured":"Bredin S, Decroocq J, Devautour C, Charpentier J, Vigneron C, P\u00e8ne F (2024) Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies. Ann Intensive Care 14(1):143","DOI":"10.1186\/s13613-024-01372-5"},{"key":"11135_CR13","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews BMJ;372 n71","DOI":"10.1136\/bmj.n71"},{"issue":"1","key":"11135_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan-a web and mobile app for systematic reviews Syst Rev;5(1):210","journal-title":"Syst Rev"},{"issue":"3","key":"11135_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","volume":"13","author":"Z Munn","year":"2015","unstructured":"Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C (2015) Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data Int J Evid Based Healthc;13(3):147-153","journal-title":"Int J Evid Based Healthc"},{"issue":"12","key":"11135_CR16","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1007\/s00134-009-1625-y","volume":"35","author":"S Roques","year":"2009","unstructured":"Roques S, Parrot A, Lavole, Ancel PY, Gounant V, Djibre M (2009) Six-month prognosis of patients with lung cancer admitted to the intensive care unit Intensive Care Med;35(12):2044-2050","journal-title":"Intensive Care Med"},{"key":"11135_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-159","volume":"11","author":"C Andrejak","year":"2011","unstructured":"Andrejak C, Terzi N, Thielen S, Bergot E, Zalcman G, Charbonneau P (2011) Admission of advanced lung cancer patients to intensive care unit: a retrospective study of 76 patients. BMC Cancer 11:159","journal-title":"BMC Cancer"},{"issue":"9","key":"11135_CR18","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1093\/annonc\/mdu234","volume":"25","author":"M Soares","year":"2014","unstructured":"Soares M, Toffart AC, Timsit JF, Burghi G, Irrazabal C, Pattison N (2014) Intensive care in patients with lung cancer: a multinational study. Ann Oncol 25(9):1829\u20131835","journal-title":"Ann Oncol"},{"issue":"7","key":"11135_CR19","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1097\/CCM.0000000000000989","volume":"43","author":"DS Lee","year":"2015","unstructured":"Lee DS, Suh GY, Ryu JA, Chung CR, Yang JH, Park CM (2015) Effect of early intervention on long-term outcomes of critically ill cancer patients admitted to ICUs. Crit Care Med 43(7):1439\u20131448","journal-title":"Crit Care Med"},{"issue":"8","key":"11135_CR20","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.3109\/10428194.2015.1106537","volume":"57","author":"P Wohlfarth","year":"2016","unstructured":"Wohlfarth P, Carlstr\u00f6m A, Staudinger T, Clauss S, Hermann A, Rabitsch W (2016) Incidence of intensive care unit admission, outcome and post intensive care survival in patients with diffuse large B-cell lymphoma. Leuk Lymphoma 57(8):1831\u20131838","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"11135_CR21","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s00415-020-10191-0","volume":"268","author":"M Decav\u00e8le","year":"2021","unstructured":"Decav\u00e8le M, Gatulle N, Weiss N, Rivals I, Idbaih A, Demeret S (2021) One-year survival of patients with high-grade glioma discharged alive from the intensive care unit J Neurol;268(2):516-525","journal-title":"J Neurol"},{"issue":"3","key":"11135_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/0885066617748874","volume":"35","author":"AS Epstein","year":"2020","unstructured":"Epstein AS, Yang A, Colbert LE, Voigt LP, Meadows J, Goldberg JI (2020) Outcomes of ICU Admission of Patients With Progressive Metastatic Gastrointestinal Cancer J Intensive Care Med;35(3):297-302","journal-title":"J Intensive Care Med"},{"issue":"1","key":"11135_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07706-3","volume":"21","author":"H Gheerbrant","year":"2021","unstructured":"Gheerbrant H, Timsit JF, Terzi N, Ruckly S, Laramas M, Levra MG (2021) Factors associated with survival of patients with solid cancer alive after intensive care unit discharge between 2005 and 2013 BMC Cancer;21(1):9","journal-title":"BMC Cancer"},{"issue":"4","key":"11135_CR24","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.chest.2021.04.056","volume":"160","author":"C Vigneron","year":"2021","unstructured":"Vigneron C, Charpentier J, Wislez M, Mira JP, Lefebvre A, Fournel L (2021) Short-term and Long-term Outcomes of Patients With Lung Cancer and Life-Threatening Complications Chest;160(4):1560-1564","journal-title":"Chest"},{"issue":"3","key":"11135_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000520097","volume":"100","author":"S Hautecloque-Rayz","year":"2022","unstructured":"Hautecloque-Rayz S, Albert-Thananayagam M, Martignene N, Le Deley MC, Carbonnelle G, Penel N (2022) Long-term outcomes and prognostic factors of patients with metastatic solid tumors admitted to the intensive care unit Oncology;100(3):173-181","journal-title":"Oncology"},{"issue":"1","key":"11135_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280027","volume":"18","author":"AC Toffart","year":"2023","unstructured":"Toffart AC, M\u2019Sallaoui W, Jerusalem S, Godon A, Bettega F, Roth G (2023) Quality of life of patients with solid malignancies at 3 months after unplanned admission in the intensive care unit: a prospective case-control study. PLoS One 18(1):e0280027","journal-title":"PLoS One"},{"issue":"4","key":"11135_CR27","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1080\/0284186X.2023.2197123","volume":"62","author":"C Vigneron","year":"2023","unstructured":"C Vigneron J Charpentier F Coussy J Alexandre F P\u00e8ne M Jamme 2023 When breast cancer comes to the ICU: outcomes and prognostic factors Acta oncologica (Stockholm, Sweden) 62 4 358 363","journal-title":"Acta oncologica (Stockholm, Sweden)"},{"key":"11135_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14070730","author":"M Garc\u00eda de Herreros","year":"2024","unstructured":"M Garc\u00eda de Herreros JC Laguna J Padrosa TD Barreto M Chicote C Font 2024 Characterisation and outcomes of patients with solid organ malignancies admitted to the intensive care unit: mortality and impact on functional status and oncological treatment Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics14070730","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"11135_CR29","first-page":"65","volume":"70","author":"V Ferrari","year":"2025","unstructured":"V Ferrari L Morand H Hyvernat R Schiappa J Dellamonica N Martis 2025 Predicting reprisal of solid cancer treatment and 60-month survival after medical intensive care: a single-centre cohort study Chemotherapy (Basel) 70 2 65 73","journal-title":"Chemotherapy (Basel)"},{"issue":"6","key":"11135_CR30","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3904\/kjim.2024.054","volume":"39","author":"SY Lee","year":"2024","unstructured":"SY Lee JW Huh SB Hong CM Lim JH Ahn 2024 Short-term and long-term outcomes of critically ill patients with solid malignancy: a retrospective cohort study Korean J Intern Med 39 6 957 966","journal-title":"Korean J Intern Med"},{"issue":"1","key":"11135_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13613-017-0250-0","volume":"7","author":"E Auclin","year":"2017","unstructured":"Auclin E, Charles-Nelson A, Abbar B, Guerot E, Oudard S, Hauw-Berlemont C (2017) Outcomes in elderly patients admitted to the intensive care unit with solid tumors. Ann Intensive Care 7(1):26. https:\/\/doi.org\/10.1186\/s13613-017-0250-0","journal-title":"Ann Intensive Care"},{"issue":"6","key":"11135_CR32","doi-asserted-by":"publisher","first-page":"e454","DOI":"10.1097\/CCM.0000000000003729","volume":"47","author":"APA Pra\u00e7a","year":"2019","unstructured":"APA Pra\u00e7a Jr. AP Nassar P Caruso 2019 Outcomes of cancer patients discharged from ICU after a decision to forgo life-sustaining therapies Crit Care Med 47 6 e454 e460","journal-title":"Crit Care Med"},{"key":"11135_CR33","doi-asserted-by":"publisher","DOI":"10.62675\/2965-2774.20250283","volume":"37","author":"MF Garc\u00eda-Aguilera","year":"2025","unstructured":"Garc\u00eda-Aguilera MF, Garc\u00eda-M\u00e9ndez N, Hern\u00e1ndez G, Fern\u00e1ndez-F\u00e9lix BM, Alexander-Le\u00f3n H, Yu-Liu Y (2025) Evaluation of prognostic factors for mortality in cancer patients with sepsis in the intensive care unit: systematic review protocol Crit Care Sci;37 :e20250283","journal-title":"Crit Care Sci"},{"issue":"7","key":"11135_CR34","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s00063-025-01320-6","volume":"120","author":"N Buchtele","year":"2025","unstructured":"Buchtele N, Munshi L (2025) Understanding cancer disease status and what it means for intensivists Med Klin Intensivmed Notfallmed;120(7):568-575","journal-title":"Med Klin Intensivmed Notfallmed"},{"issue":"6","key":"11135_CR35","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00134-024-07454-z","volume":"50","author":"A Lafarge","year":"2024","unstructured":"Lafarge A, Chean D, Whiting L, Clere-Jehl R (2024) Management of hematological patients requiring emergency chemotherapy in the intensive care unit Intensive Care Med;50(6):849-860","journal-title":"Intensive Care Med"},{"issue":"7","key":"11135_CR36","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1093\/annonc\/mdv028","volume":"26","author":"D Hui","year":"2015","unstructured":"Hui D, Bansal S, Park M, Reddy A, Cortes J, Fossella F (2015) Differences in attitudes and beliefs toward end-of-life care between hematologic and solid tumor oncology specialists. Ann Oncol 26(7):1440\u20131446","journal-title":"Ann Oncol"},{"key":"11135_CR37","volume":"36","author":"K Puxty","year":"2024","unstructured":"Puxty K, Keith R, McPeake J, Morrison D, Shaw M (2024) Rate of non-metastatic solid tumor progression following critical illness: a prospective cohort study of UK Biobank participants Crit Care Sci;36:e20240018en","journal-title":"Crit Care Sci"},{"key":"11135_CR38","doi-asserted-by":"publisher","DOI":"10.62675\/2965-2774.20260204","volume":"38","author":"C Silva","year":"2026","unstructured":"Silva C, Ara\u00fajo B (2026) Discrepancies in intensive care unit triage decisions for patients with advanced cancer: a Brazilian survey of intensivists and oncologists Crit Care Sci;38:e20260204","journal-title":"Crit Care Sci"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11135-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11135-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11135-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:51:58Z","timestamp":1790322718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-11135-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["11135"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11135-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"28 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The declaration is not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used Grammarly (Grammarly, San Francisco, USA) to revise the English language. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the manuscript.","order":2,"name":"Ethics","label":"Declaration of AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"915"}}